Amyris: Show Us The Money

Dec. 09, 2022 6:22 PM ETAmyris, Inc. (AMRS), GVDNY279 Comments
In the Ruff Research profile picture
In the Ruff Research
1.16K Followers

Summary

  • Amyris is on the cusp of closing a record strategic transaction slated to generate ~$500mm in total cash value.
  • All indications point to the strategic transaction closing in the next two to three weeks.
  • Cash balances by year-end (or shortly thereafter pending funding) are projected to be >$350mm after the strategic transaction close.
  • Q4’22 revenue guidance of $100mm is achievable and on track for ingredients, licensing and D2C fronts; with brick & mortar sales bearing further examination.
  • Q4’23 revenue and operating income margins, while tight, may be a bit of a stretch goal.

Hands hold up US $100 bill with more in background

Amyris on the Cusp of Closing a $500MM Cash Value Marketing Rights Transaction for Two Molecules

RapidEye/E+ via Getty Images

New to Amyris (AMRS)? I suggest you read my first and second Seeking Alpha articles as

Author Compilation

Author Compilation

Q2'22 Earnings Call

/seekingalpha.com/article/4532027-amyris-inc-amrs-ceo-john-melo-on-q2-2022-results-earnings-call-transcript

Q3'22 Excerpt

investors.amyris.com/sec-filings

Q3'22 Press Release

amyris.com/newsroom

Amyris, Inc. 2022 Q3 - Results - Earnings Call Presentation (<span class='ticker-hover-wrapper'>NASDAQ:<a href='https://seekingalpha.com/symbol/AMRS' title='Amyris, Inc.'>AMRS</a></span>)

seekingalpha.com/article/4554999-amyris-inc-2022-q3-results-earnings-call-presentation

Q3'22 Earnings Call Excerpts

seekingalpha.com/article/4555043-amyris-inc-amrs-q3-2022-earnings-call-transcript

Amyris Press Release on Cyber Monday

investors.amyris.com/2022-11-30-AMYRIS-CONSUMER-BRANDS-DELIVER-80-CYBER-MONDAY-LIKE-FOR-LIKE-GROWTH

Q3'22 Earnings Call Excerpts

seekingalpha.com/article/4555043-amyris-inc-amrs-q3-2022-earnings-call-transcript

Author Compilation

Author Compilation

Author Compilation

Author Compilation

hemi-squalane-vs-squalane

abeautyedit.com/hemi-squalane-vs-squalane/

hemi-squalane-vs-squalane/

abeautyedit.com/hemi-squalane-vs-squalane/

hemi-squalane-vs-squalane/

abeautyedit.com/hemi-squalane-vs-squalane/

difference-between-squalane-and-hemisqualane

aprinnova.com/knowledge/what-is-the-difference-between-squalane-and-hemisqualane

q1-2022-results-earnings-call-transcript

seekingalpha.com/article/4509715-amyris-inc-amrs-ceo-john-melo-on-q1-2022-results-earnings-call-transcript

Oppenheimer Conference

investors.amyris.com/events-and-presentations#past

Oppenheimer Conference

investors.amyris.com/events-and-presentations#past

Q2'22 Earnings Call

seekingalpha.com/article/4532027-amyris-inc-amrs-ceo-john-melo-on-q2-2022-results-earnings-call-transcript

Author Compilation

Author Compilation

Soliance_and_Amyris_tieup_to_produce_squalane

cosmeticsbusiness.com/news/article_page/Soliance_and_Amyris_tieup_to_produce_squalane/55259

Renewable-Ingredient-Firm-Signs-Givaudan-Boasts-10-Mil-quotPipeline-Of-Interest

hbw.pharmaintelligence.informa.com/RS017479/Renewable-Ingredient-Firm-Signs-Givaudan-Boasts-10-Mil-quotPipeline-Of-Interestquot

Givaudan Investor Presentation

givaudan.com/files/giv-2022-investor-presentation-jul.pdf

giv-2022-investor-presentation-jul

www.givaudan.com/files/giv-2022-investor-presentation-jul.pdf

Q2'22 Earnings Call Excerpts

seekingalpha.com/article/4524890-givaudans-gvdbf-ceo-gilles-andrier-on-q2-2022-results-earnings-call-transcript

givaudans-gvdbf-ceo-gilles-andrier-on-q2-2022-results-earnings-call-transcript

seekingalpha.com/article/4524890-givaudans-gvdbf-ceo-gilles-andrier-on-q2-2022-results-earnings-call-transcript

financial-results/key-figures

www.givaudan.com/investors/financial-results/key-figures

compensation-and-governance

integratedreport.givaudan.com/#/compensation-and-governance

Author Compilation

Author Compilation

Author Analyses

Author Analyses

Author Compilation

Author Compilation

amrs-investor-presentation-slideshow

seekingalpha.com/article/4414895-amyris-amrs-investor-presentation-slideshow

Author Analyses

Author Analyses

Author Analyses

Author Analyses

investors.amyris.com/sec-filings

investors.amyris.com/sec-filings

Author Analyses

Author Analyses

Author Analyses

Author Analyses

investors.amyris.com/events-and-presentations#past

investors.amyris.com/events-and-presentations#past

investors.amyris.com/events-and-presentations#past

investors.amyris.com/events-and-presentations#past

Author Analyses

Author Analyses

Author Analyses

Author Analyses

Author Analyses

Author Analyses

Author Analyses

Author Analyses

investors.amyris.com/2022-11-28-AMYRIS-CONSUMER-BRANDS-DELIVER-RECORD-BLACK-FRIDAY-WEEK-SALES

investors.amyris.com/2022-11-28-AMYRIS-CONSUMER-BRANDS-DELIVER-RECORD-BLACK-FRIDAY-WEEK-SALES

seekingalpha.com/article/4532027-amyris-inc-amrs-ceo-john-melo-on-q2-2022-results-earnings-call-transcript

seekingalpha.com/article/4532027-amyris-inc-amrs-ceo-john-melo-on-q2-2022-results-earnings-call-transcript

investors.amyris.com/sec-filings?cat=2

investors.amyris.com/sec-filings?cat=2

seekingalpha.com/article/4555043-amyris-inc-amrs-q3-2022-earnings-call-transcript

seekingalpha.com/article/4555043-amyris-inc-amrs-q3-2022-earnings-call-transcript

seekingalpha.com/uploads/2022/8/7/11765171-16598821362437603_origin.png

seekingalpha.com/uploads/2022/8/7/11765171-16598821362437603_origin.png

seekingalpha.com/article/4555043-amyris-inc-amrs-q3-2022-earnings-call-transcript

seekingalpha.com/article/4555043-amyris-inc-amrs-q3-2022-earnings-call-transcript

investors.amyris.com/sec-filings?cat=2

investors.amyris.com/sec-filings?cat=2

Author Analyses

Author Analyses

Author Analyses

Author Analyses

Author Compilation

Author Compilation

investors.amyris.com/sec-filings?cat=2

investors.amyris.com/sec-filings?cat=2

investors.amyris.com/sec-filings?cat=2

investors.amyris.com/sec-filings?cat=2

usimports.info/buyers-amyris/data-1.html

usimports.info/buyers-amyris/data-1.html

Author Compilation

Author Compilation

seekingalpha.com/article/4532027-amyris-inc-amrs-ceo-john-melo-on-q2-2022-results-earnings-call-transcript

seekingalpha.com/article/4532027-amyris-inc-amrs-ceo-john-melo-on-q2-2022-results-earnings-call-transcript

Author Compilation

Author Compilation

This article was written by

In the Ruff Research profile picture
1.16K Followers
I am a die-hard value investor and my experience runs the gamut of Investment Banking, Corporate Development, Board Memberships and Operational responsibility. I worked in Morgan Stanley's Investment Banking Division in both Mergers and Acquisitions and Corporate Finance for several Years. Thereafter, I spent 15+ years as working in Executive Corporate Development,Strategic Planning, and Finance roles with Fortune 500 and Private Companies spanning Technology, Healthcare, Finance and Real Estate. My specialization was in valuation, due diligence, acquisition and integration of companies ranging in size from $2 Billion to as little as $5MM in deal size both domestically and internationally. I have also been part of two founding teams in early stage startups having led capital raising efforts. I hold an MBA from the Wharton Business School, a Masters in Industrial Engineering from the University of California Berkeley and two undergraduate degrees in Engineering and Economics from The Universtiy of California of Berkeley. I have had the pleasure of serving on three boards (i.e., One Publicly traded, One Private Company, and One Academic University). I enjoy investing and look forward to helping others find hidden value in companies.

Disclosure: I/we have a beneficial long position in the shares of AMRS either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Additional disclosure: We truly pride ourselves on conducting extensive primary & secondary research, analyses, and/or interviews with Senior Management, Partners, and/or Customers in order to identify and vet undervalued investment opportunities. That said, we aren't always right and these are just our humble opinions. We always encourage everyone to do their own homework and research and as the saying goes... BUYER BEWARE. In the meantime, Happy investing!

Recommended For You

Comments (279)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.